tiprankstipranks
Trending News
More News >
Mankind Pharma Ltd. (IN:MANKIND)
:MANKIND
India Market

Mankind Pharma Ltd. (MANKIND) Income Statement

Compare
11 Followers

Mankind Pharma Ltd. Income Statement

Last quarter (Q1 2026), Mankind Pharma Ltd.'s total revenue was ₹35.70B, an increase of 23.40% from the same quarter last year. In Q1, Mankind Pharma Ltd.'s net income was ₹4.38B. See Mankind Pharma Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 122.07B₹ 103.35B₹ 87.43B₹ 77.82B₹ 62.14B
Gross Profit
₹ 87.18B₹ 70.14B₹ 33.88B₹ 53.12B₹ 43.89B
Operating Expenses
₹ 26.92B₹ 29.27B₹ 17.70B₹ 34.33B₹ 27.83B
Depreciation and Amortization
₹ 6.21B₹ 3.98B₹ 3.26B₹ 1.67B₹ 1.19B
EBITDA
₹ 30.18B₹ 28.09B₹ 20.27B₹ 21.47B₹ 18.17B
Operating Income
₹ 60.26B₹ 40.87B₹ 16.18B₹ 18.61B₹ 16.06B
Other Income/Expenses
₹ -35.10B₹ -16.87B₹ 532.64M₹ 1.13B₹ 851.50M
Pretax Income
₹ 25.16B₹ 23.99B₹ 16.71B₹ 19.75B₹ 16.92B
Net Income
₹ 19.91B₹ 19.13B₹ 12.82B₹ 14.33B₹ 12.65B
Per Share Metrics
Basic EPS
₹ 49.17₹ 47.75₹ 32.00₹ 35.78₹ 31.59
Diluted EPS
₹ 49.09₹ 47.68₹ 32.00₹ 35.78₹ 31.59
Weighted Average Shares Outstanding
404.67M 400.59M 400.59M 400.59M 400.59M
Weighted Average Shares Outstanding (Diluted)
404.67M 401.17M 400.59M 400.59M 400.59M
Currency in INR

Mankind Pharma Ltd. Earnings and Revenue History